Xiaolan Lu

1.9k total citations
42 papers, 1.5k citations indexed

About

Xiaolan Lu is a scholar working on Epidemiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaolan Lu has authored 42 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Molecular Biology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaolan Lu's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (7 papers) and Gut microbiota and health (7 papers). Xiaolan Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (7 papers) and Gut microbiota and health (7 papers). Xiaolan Lu collaborates with scholars based in China, United States and Japan. Xiaolan Lu's co-authors include Haitao Shi, Octavian Henegariu, Cheng‐Kui Qu, Gen‐Sheng Feng, Lei Dong, Juhui Zhao, Jiong Jiang, Xiaoyan Dang, Zuhong Xu and Gefei Zhou and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaolan Lu

39 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolan Lu China 17 675 270 216 169 152 42 1.5k
Gabsik Yang South Korea 24 912 1.4× 226 0.8× 313 1.4× 176 1.0× 153 1.0× 68 1.9k
Yuan‐Yen Chang Taiwan 29 746 1.1× 303 1.1× 150 0.7× 195 1.2× 186 1.2× 81 2.0k
Kazuhiro Ohgami Japan 22 630 0.9× 102 0.4× 168 0.8× 127 0.8× 124 0.8× 43 1.8k
Ji Hye Yang South Korea 29 1.2k 1.7× 453 1.7× 192 0.9× 219 1.3× 193 1.3× 91 2.3k
Hyesook Lee South Korea 23 777 1.2× 128 0.5× 164 0.8× 96 0.6× 151 1.0× 87 1.6k
Sung Su Yea South Korea 25 524 0.8× 94 0.3× 284 1.3× 115 0.7× 149 1.0× 44 1.5k
Shung-Te Kao Taiwan 26 659 1.0× 148 0.5× 227 1.1× 194 1.1× 187 1.2× 55 1.7k
Jin‐Won Hyun South Korea 22 771 1.1× 176 0.7× 138 0.6× 55 0.3× 103 0.7× 30 1.3k
Jaume Amengual United States 30 1.6k 2.3× 264 1.0× 291 1.3× 453 2.7× 53 0.3× 49 2.6k
Phil‐Dong Moon South Korea 26 597 0.9× 52 0.2× 460 2.1× 332 2.0× 209 1.4× 103 2.0k

Countries citing papers authored by Xiaolan Lu

Since Specialization
Citations

This map shows the geographic impact of Xiaolan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Lu more than expected).

Fields of papers citing papers by Xiaolan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Lu. The network helps show where Xiaolan Lu may publish in the future.

Co-authorship network of co-authors of Xiaolan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolan Lu. A scholar is included among the top collaborators of Xiaolan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolan Lu. Xiaolan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Ameng, Sinan Xiao, Ying Wang, et al.. (2024). Metabolic abnormalities, liver enzymes increased risk of gallstones: a cross-sectional study and multivariate mendelian randomization analysis. Internal and Emergency Medicine. 20(2). 501–508. 3 indexed citations
2.
Chen, Yueying, et al.. (2024). Gut microbiota metabolite trimethylamine N-oxide promoted NAFLD progression by exacerbating intestinal barrier disruption and intrahepatic cellular imbalance. International Immunopharmacology. 142(Pt B). 113173–113173. 23 indexed citations
3.
Xu, Jing‐Yuan, et al.. (2024). Urolithin A exerts anti-tumor effects on gastric cancer via activating autophagy-Hippo axis and modulating the gut microbiota. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(9). 6633–6645. 3 indexed citations
4.
Xu, Jing‐Yuan, Longyun Wu, Jiang Deng, et al.. (2023). Population attributable fractions of fatty liver disease for type 2 diabetes Mellitus. BMC Endocrine Disorders. 23(1). 201–201. 1 indexed citations
5.
Wu, Longyun, et al.. (2023). Akkermansia muciniphila and Bifidobacterium bifidum Prevent NAFLD by Regulating FXR Expression and Gut Microbiota. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 25 indexed citations
6.
Dong, Lei, Xiaolan Lu, Haitao Shi, et al.. (2022). Distinctions Between Fecal and Intestinal Mucosal Microbiota in Subgroups of Irritable Bowel Syndrome. Digestive Diseases and Sciences. 67(12). 5580–5592. 15 indexed citations
7.
Xu, Jing‐Yuan, Yatao Wang, Xiaoling Li, et al.. (2022). Prediction model using readily available clinical data for colorectal cancer in a chinese population. The American Journal of the Medical Sciences. 364(1). 59–65. 2 indexed citations
8.
Lu, Xiaolan, et al.. (2021). Effect and mechanism of dexmetopyrimidine on endotoxin-induced acute lung injury in rats. Minerva Surgery. 77(3). 301–303.
9.
Deng, Jiang, Yonghong Zhang, Haitao Shi, et al.. (2021). The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease. Frontiers in Endocrinology. 12. 744710–744710. 4 indexed citations
10.
Luo, Yi, Yang Zhou, Yusheng Chen, Xiaolan Lu, & Yingjun Quan. (2021). Genomic and immunological features of microsatellite instability in colon cancer. Gene. 781. 145534–145534. 5 indexed citations
11.
Li, Ting, Yan Geng, Haitao Shi, et al.. (2019). Target genes associated with lipid and glucose metabolism in non-alcoholic fatty liver disease. Lipids in Health and Disease. 18(1). 211–211. 15 indexed citations
12.
Shi, Haitao, Ameng Shi, Lei Dong, et al.. (2016). Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress. Clinical Nutrition. 35(6). 1366–1373. 154 indexed citations
13.
Zhao, Gang, Lei Dong, Haitao Shi, et al.. (2016). MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway. Oncology Reports. 36(3). 1709–1716. 28 indexed citations
14.
Wei, Bin, Haitao Shi, Xiaolan Lu, et al.. (2015). Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer. Molecular Medicine Reports. 12(2). 2075–2081. 11 indexed citations
15.
Shi, Haitao, Lei Dong, Xiaoyan Dang, et al.. (2013). Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflammation Research. 62(6). 581–587. 78 indexed citations
16.
Zhao, Juhui, Jinhai Wang, Lei Dong, et al.. (2011). A protease inhibitor against acute stress-induced visceral hypersensitivity and paracellular permeability in rats. European Journal of Pharmacology. 654(3). 289–294. 32 indexed citations
17.
Lu, Xiaolan, Eiji Uchida, Shigeki Yokomuro, et al.. (2008). Features and Choice of Treatment of Acute and Chronic Pancreatic Pseudocysts — with Special Reference to Invasive Intervention. Pancreatology. 8(1). 30–35.
18.
Zhang, Quanbin, Ning Li, Gefei Zhou, et al.. (2003). In vivo antioxidant activity of polysaccharide fraction from Porphyra haitanesis (Rhodephyta) in aging mice. Pharmacological Research. 48(2). 151–155. 212 indexed citations
19.
20.
Qu, Cheng‐Kui, et al.. (1998). Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal Adhesion. Journal of Biological Chemistry. 273(33). 21125–21131. 343 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabsik Yang Breakdown of academic impact, for papers by Yuan‐Yen Chang Breakdown of academic impact, for papers by Kazuhiro Ohgami Breakdown of academic impact, for papers by Ji Hye Yang Breakdown of academic impact, for papers by Hyesook Lee Breakdown of academic impact, for papers by Sung Su Yea Breakdown of academic impact, for papers by Shung-Te Kao Breakdown of academic impact, for papers by Jin‐Won Hyun Breakdown of academic impact, for papers by Jaume Amengual Breakdown of academic impact, for papers by Phil‐Dong Moon
Rankless by CCL
2026